Shin Nippon Biomedical Laboratories, Ltd. (FRA:YB3)

FRA:YB3 Revenue

Shin Nippon Biomedical Laboratories had revenue of 8.29B JPY in the quarter ending September 30, 2025, with 19.11% growth. This brings the company's revenue in the last twelve months to 34.67B, up 28.06% year-over-year. In the fiscal year ending March 31, 2025, Shin Nippon Biomedical Laboratories had annual revenue of 32.41B with 22.54% growth.

• Revenue (ttm): 34.67B JPY
• Revenue Growth: +28.06%
• P/S Ratio: 1.84
• Revenue / Employee: 22.65M JPY
• Employees: 1,531
• Market Cap: 367.15M EUR

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	32.41B	5.96B	22.54%
Mar 31, 2024	26.45B	1.36B	5.42%
Mar 31, 2023	25.09B	7.34B	41.37%
Mar 31, 2022	17.75B	2.64B	17.46%
Mar 31, 2021	15.11B	549.00M	3.77%